Sign In
Buy ILMN
$168.06
-2.87 (-1.68%)
At Close: Jun 04, 2026
Illumina Narrowly Squeaks Out First-Quarter Beat As Grail Battle Continues
04:55pm, Tuesday, 25'th Apr 2023
Illumina narrowly topped first-quarter forecasts Tuesday as its fight to retain its Grail subsidiary continues. ILMN stock dipped.
EXEL or ILMN: Which Is the Better Value Stock Right Now?
12:57pm, Tuesday, 25'th Apr 2023
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixis (EXEL) and Illumina (ILMN). But which of these two stocks is more attractive to value investors?
Carl Icahn Writes Another Open Letter to Illumina Shareholders
12:38pm, Monday, 24'th Apr 2023
Sunny Isles Beach, Florida, April 24, 2023 — Today, Carl C. Icahn released the following open letter to the shareholders of Illumina, Inc. ( ILMN , Financial).
Here's Why You Shouldn't Buy the Dip With Illumina Stock
08:10am, Friday, 14'th Apr 2023
Illumina hasn't been a great investment over the last five years. Its troubles with the Grail acquisition are only part of the story.
Is There Any Hope for Illumina Stock?
09:37am, Saturday, 08'th Apr 2023
Illumina's latest earnings report was a bit of a let down. It will also probably be forced to divest a company it recently acquired.
Carl Ican Issues Another Letter to Illumina Shareholders
05:55pm, Wednesday, 05'th Apr 2023
Investor Contacts:
Carl Icahn says Illumina's appeal of FTC order to divest Grail is ‘an almost impossible battle'
04:33pm, Wednesday, 05'th Apr 2023
Carl Icahn shares common ground with the FTC, which argued that Illumina's acquisition of cancer test developer Grail would stifle competition and innovation.
Illumina's (ILMN) NovaSeq X Exceeds 200 Order Milestone
12:56pm, Wednesday, 05'th Apr 2023
Illumina's (ILMN) NovaSeq X records the strongest pre-launch demand ever witnessed for any instrument.
Carl Icahn Writes Another Letter to Illumina Shareholders
05:52pm, Tuesday, 04'th Apr 2023
Sunny Isles Beach, Florida, April 3, 2023 — Today, Carl C. Icahn released the following open letter to the shareholders of Illumina, Inc. ( ILMN , Financial).
FTC orders Illumina to divest cancer detection test maker Grail to protect competition; Illumina to appeal
01:55pm, Monday, 03'rd Apr 2023
The Federal Trade Commission (FTC) has issued an Opinion and Order requiring DNA sequencing provider, Illumina Inc (NASDAQ:ILMN), to divest Gral Inc, which makes a multi-cancer early detection (MCE
FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle
01:25pm, Monday, 03'rd Apr 2023
The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell on the news.
Illumina: ‘Ichan doesn't fully understand growth projections of this company,' analyst says
11:49am, Monday, 03'rd Apr 2023
RBC Capital Markets Equity Research Analyst Conor McNamara joins Yahoo Finance Live to discuss the proxy battle between Illumina and activist investor Carl Ichan, risks of closing the GRAIL acquisitio
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
11:11am, Monday, 03'rd Apr 2023
The decision reverses an administrative judge's ruling that dismissed the FTC's initial challenge of Illumina's $7.1 billion Grail deal.
FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail
10:44am, Monday, 03'rd Apr 2023
The agency said the combination would hurt competition for cancer-detection tests while raising prices.
Carl Icahn blasts Illumina for nearly doubling CEO's pay despite steep drop in market value
12:17pm, Friday, 31'st Mar 2023
Activist investor Carl Icahn ramped up his proxy fight against Illumina with a blistering statement.
